Search Within

Sandeep Sunder Raj

Formats
  1. Meeting Abstract (13)
  2. Journal Article (9)
  3. Correspondence (1)
Groups
  1. GME, Medicine (23)
  2. Graduate Medical Education (23)
  3. Hematology-Oncology Fellows (23)
  4. Department of Medicine (20)
  5. Hematologic Malignancies, Division of (20)
  6. Center for Hematologic Malignancies (17)

More Groups

People
  1. Roni Shouval (17)
  2. Miguel-Angel Perales (15)
  3. Gilles Salles (12)
  4. Maria Palomba (12)
  5. Gunjan Shah (11)
  6. Michael Scordo (11)

More People

Years
  1. 2025 (4)
  2. 2024 (10)
  3. 2023 (4)
  4. 2022 (2)
  5. 2019 (1)
  6. 2018 (1)

More Years

Publications
  1. Blood (9)
  2. Bone Marrow Transplantation (3)
  3. Annals of Surgical Oncology (1)
  4. Blood Cancer Discovery (1)
  5. Blood Cancer Journal (1)
  6. British Journal of Haematology (1)

More Publications

Publishers
  1. American Society of Hematology (9)
  2. Nature Publishing Group (5)
  3. American Association for Cancer Research (3)
  4. American Society of Clinical Oncology (1)
  5. Cell Press (1)
  6. John Wiley & Sons (1)

More Publishers

Results (23)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Scalable log-ratio lasso regression for enhanced microbial feature selection with FLORAL
    Journal Article

    Fei, T.; Funnell, T.; Waters, N. R.; Raj, S. S.; Baichoo, M.; Sadeghi, K.; Dai, A.; Miltiadous, O.; Shouval, R.; Lv, M.; more...
    Cell Reports Methods (2024)

    Fulltext@MSK | Save
  • Atrial arrhythmias following CAR-chimeric antigen receptor T-cell therapy: Incidence, risk factors and biomarker profile
    Journal Article

    Shouval, R.; Goldman, A.; Flynn, J. R.; El-Moghraby, A.; Rehman, M.; Devlin, S. M.; Corona, M.; Landego, I.; Lin, R. J.; Scordo, M.; more...
    British Journal of Haematology (2024)

    Fulltext@MSK | Save
  • Multicenter, randomized phase II study of epcoritamab for patients with large B-cell lymphomas achieving a partial response after CD19-directed CAR T-cell therapy (CAR-T)
    Meeting Abstract

    Bock, A. M.; Raj, S.; Giri, S.; Leslie, L. A.; Patel, D. A.; Iqbal, M.; Grover, N. S.; Hu, B.; Perales, M. A.; Nowakowski, G. S.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Development and validation of an automated computational approach to grade immune effector cell-associated hematotoxicity
    Journal Article

    Liang, E. C.; Rejeski, K.; Fei, T.; Albittar, A.; Huang, J. J.; Portuguese, A. J.; Wu, Q.; Raj, S.; Subklewe, M.; Shouval, R.; more...
    Bone Marrow Transplantation (2024)

    Fulltext@MSK | Save
  • First fever between lymphodepletion and day 30 after CAR-T cell therapy: Patterns, origins, and implications in lymphoma patients
    Meeting Abstract

    Melica, G.; Luna, A.; Fei, T.; Corona, M.; Dahi, P. B.; Fein, J.; Giralt, S. A.; Raj, S.; Landego, I.; Lin, R. J.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • An inflammatory biomarker signature reproducibly predicts CAR-T treatment failure in patients with aggressive lymphoma across the ZUMA trials cohorts
    Meeting Abstract

    Raj, S.; Xie, J.; Fei, T.; Song, Q.; Kim, J. J.; To, C.; van den Brink, M. R. M.; Perales, M. A.; Mattie, M.; Shouval, R.
    Blood (2023)

    Fulltext@MSK | Save
  • A reproducible inflammatory biomarker signature identifies non-Hodgkin lymphoma patients at high risk of CAR-T treatment failure across different cohorts
    Meeting Abstract

    Raj, S.; Perales, M. A.; Fei, T.; Fein, J.; Tomas, A. A.; De LaPuerta, M. C.; Dahi, P.; Danylesko, I.; Epstein-Peterson, Z.; Fried, S.; more...
    Bone Marrow Transplantation (2023)

    Fulltext@MSK | Save
  • Gut microbiota associations with GD2/GD3 vaccine response in patients with high-risk neuroblastoma
    Meeting Abstract

    Miltiadous, O.; Nguyen, C.; Cheung, I.; Kushner, B.; Mauguen, A.; Waters, N.; Dai, A.; Kivovich, V.; Littmann, E.; Harford, L.; more...
    Pediatric Blood and Cancer (2023)

    Fulltext@MSK | Save
  • Inflammatory biomarker clusters are predictive of response and toxicity in large B-cell lymphoma treated with CD19 CAR-T cell therapy
    Meeting Abstract

    Raj, S.; Perales, M. A.; Fein, J. A.; Tomas, A. A.; Batlevi, C. L.; De Lapuerta, M. C.; Dahi, P. B.; Danylesko, I.; Fried, S.; Funnell, T.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • CD19 epitope masking by tafasitamab leads to delays in subsequent use of CD19 CAR T-cell therapy in two patients with aggressive mature B-cell lymphomas
    Correspondence

    Fitzgerald, K. N.; Quesada, A. E.; von Keudell, G.; Raj, S.; Lewis, N. E.; Dogan, A.; Salles, G.; Palomba, M. L.
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save